Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tsubota Laboratory Inc. (4890:JPX), powered by AI.
Tsubota Laboratory Inc. is currently trading at ¥223. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tsubota Laboratory Inc. on Alpha Lenz.
Tsubota Laboratory Inc.'s P/E ratio is 27.7.
“Tsubota Laboratory Inc. trades at a P/E of 27.7 (premium valuation) with solid ROE of 13.9%. 3Y revenue CAGR of 28.4% highlights clear growth momentum.”
Ask for details →Tsubota Laboratory Inc. is a company specializing in the development and commercialization of innovative health and wellness products. It focuses primarily on advancing new technologies and methodologies to support vision health, among other medical and lifestyle areas. The firm leverages cutting-edge research to create solutions that cater to various demographics concerned with eye care and general well-being. By integrating scientific research with practical product development, Tsubota Laboratory significantly impacts the healthcare and wellness sector. It often collaborates with academic institutions and other industry players to enhance its product offerings. Based in Japan, Tsubota Laboratory plays a crucial role in the expanding intersection of healthcare technology and consumer wellness products, reflecting the growing market demand for preventative care solutions worldwide.
“Tsubota Laboratory Inc. trades at a P/E of 27.7 (premium valuation) with solid ROE of 13.9%. 3Y revenue CAGR of 28.4% highlights clear growth momentum.”
Ask for details →Tsubota Laboratory Inc. (ticker: 4890) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 17 employees. Market cap is $5.7B.
The current price is 223 with a P/E ratio of 27.74x and P/B of 3.6x.
ROE is 13.93% and operating margin is 17.35%. Annual revenue is $1.4B.